Olaparib

Home > API & Intermediate > Antineoplastic Agents > Olaparib Manufacturers > Olaparib

Olaparib

CAS NO.： 763113-22-0

FOB Price： NEGOTIABLE Get Latest Price

Specification： ≥99.5%

Documentation： Get COA after inquiry

Lead Time： 14-30 days

Max Capacity： -

Packing： 1KG/BOTTLE

Product Detail

Properties

English Name: Olaparib

CAS No.: 763113-22-0

Molecular formula: C24H23FN4O3

Molecular weight: 434.46

EINECS No.: 642-941-5

Density: 1.43

Uses: olapani is a novel inhibitor of poly ADP ribose polymerase (PARP), including PARP1, PARP2, and parp3. PARP mediates a DNA repair mechanism, which plays an important role in DNA damage repair and apoptosis. Therefore, Ola Pani's specific DNA damage repair mechanism for targeted cells plays an important role in attacking the key loopholes in BRCA1 and BRCA2 mutant cancer cells, and can be used in the mutation of the breast cancer susceptibility gene (BRCA). Maintenance therapy for patients with recurrent severe ovarian cancer sensitive to platinum drugs.

Properties

Ola Pani is a chemotherapeutic agent for the treatment of recurrent or advanced ovarian cancer and metastatic breast cancer in patients with specific mutations and previous history of chemotherapy. Olapani is sold under the lynparza brand in the form of oral tablets and was originally designated as maintenance therapy or monotherapy for adult patients with recurrent epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer.

CAS No.

763113-22-0

Formula

C24H23FN4O3

Molecular Mass

434.46300

Exact Mass

434.17500

PSA

86.37000

Logp

2.22320